抗胆固醇药物对痴呆风险的影响:系统审查和元分析协议
Elham Maraghi1, Ali Reza Safarpour2, Maryam Hajmohammadi3
1Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran.
Basic and clinical neuroscience
|July 14, 2025
概括
这项研究评估了抗胆固醇药物如何影响痴呆风险. 这些发现将有助于医疗保健专业人员评估认知障碍风险,特别是在服用多种药物的老年人中.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默病是最常见的痴呆症.
- 抗胆固醇药物可能会影响痴呆症风险因素.
- 关于抗胆固醇药物和痴呆风险的现有研究产生了不一致的结果.
研究的目的:
- 系统地审查和元分析抗胆固醇药物对痴呆风险的影响.
- 提供关于抗胆固醇药物干预和痴呆风险的确的临床研究结果.
主要方法:
- 1988年至2021年间发表的研究的系统审查和元分析.
- 在多个数据库 (WoS,EMBASE,PubMed,Scopus,ProQuest) 和灰色文献中进行了搜索.
- 包括队列,病例控制和临床试验研究;使用既有工具评估偏差风险;使用随机或固定的效果模型进行元分析.
主要成果:
- 该研究综合了来自各种研究设计的数据,以评估抗胆固醇药物对痴呆风险的影响.
- 使用森林地块,汇总表和叙事总结来呈现结果.
- 方法的异质性指导了元分析模型的选择 (随机或固定的效果).
结论:
- 调查结果将为医生和医疗保健专业人员提供有关抗胆固醇药物处方的信息.
- 强调需要对老年患者,特别是那些多药患者进行仔细的痴呆风险评估.
- 旨在澄清抗胆固醇药物使用与痴呆症和阿尔茨海默病等认知障碍之间的关系.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
843
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
843
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
Dementia
169
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
169
Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
Cholinergic Antagonists: Therapeutic Uses
880
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
880
Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385


